Cellectar Biosciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma, CLR 125, which intends to treat micro metastatic disease, CLR 124, which could detect tumors and metastases in a broad range of cancers, and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination. The company was founded on June 24, 1996 and is headquartered in Florham Park, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
11
Frequently Asked Questions
What is Market Cap of Cellectar Biosciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Cellectar Biosciences Inc market cap is $16.6M.
What is the 52-week high for Cellectar Biosciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cellectar Biosciences Inc 52 week high is $67.50 as of September 20, 2025.
What is the 52-week low for Cellectar Biosciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cellectar Biosciences Inc 52 week low is $4.11 as of September 20, 2025.
What is Cellectar Biosciences Inc stock price today?
Cellectar Biosciences Inc stock price today is $5.20.
What was Cellectar Biosciences Inc stock price yesterday?
Cellectar Biosciences Inc stock price yesterday was $5.49.
What is the PE ratio of Cellectar Biosciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Cellectar Biosciences Inc’s P/E ratio is -0.25.
What is the Price-to-Book ratio of Cellectar Biosciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Cellectar Biosciences Inc P/B ratio is 1.6934.
What is the 50-day moving average of Cellectar Biosciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Cellectar Biosciences Inc 50-day moving average is $4.89.
How many employess does Cellectar Biosciences Inc has?
